|
July 2009
Happy July! I hope you have a fabulous summer!
NEW PRODUCT!
After careful consideration of the choices available, we have decided to offer Latisse™ to our clients.
Latisse™ is the first and only prescription treatment approved by the FDA for inadequate or insufficient eyelashes, growing them longer, fuller and darker. This product is applied to the eyelid along the lash line which will, over about 12 to 16 weeks, result in thicker, fuller, darker, eyelashes.
|
Unretouched clinical photos of actual LATISSE™ users. In the clinical trial, 78% of LATISSE™ users experienced >1-grade increase vs 18% for vehicle, and 33% experienced >2-grade increase vs 1% for vehicle, on the 4-point Global Eyelash Assessment (GEA) scale* at week 16.¹ Individual results may vary.
LATISSE™ (bimatoprost ophthalmic solution) 0.03% is the first and only FDA-approved prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker, and darker.
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
¹ Data on file, Allergan, Inc., 2008; Study No. 192024-032. |
Introductory Offer:
Lakewood Laser Clients
will receive 10% off for a limited time only.
Regular Price: $120
Latisse™ is a prescription item and we will need to do a brief consultation and medical review.
Call to schedule an appointment for a Latisse™ prescription today!
If you are interested in purchasing Latisse™, please give us a call at 303.202.0927 for more information and to make an appointment.
Click here to download and print the LatisseTMConsent Form.
For more information on Latisse™, please click here, and visit our website at www.lakewoodlaser.com for more information on the other products and services we offer. Remember, how you look reflects how your feel!
|
